A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn's disease (CACD)
- 15 April 1998
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 114, A1080
- https://doi.org/10.1016/s0016-5085(98)84394-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: